Berkshire Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5M | Hold |
|
|||||
|
2025
Q1 | $1.45M | Sell |
|
|||||
|
2024
Q4 | $1.6M | Sell |
|
|||||
|
2024
Q3 | $2.06M | Hold |
|
|||||
|
2024
Q2 | $2.06M | Sell |
|
|||||
|
2024
Q1 | $2M | Sell |
|
|||||
|
2023
Q4 | $1.98M | Sell |
|
|||||
|
2023
Q3 | $1.7M | Sell |
|
|||||
|
2023
Q2 | $1.74M | Buy |
|
|||||
|
2023
Q1 | $1.52M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1.44M | Sell |
|
|||||
|
2022
Q2 | $1.73M | Sell |
|
|||||
|
2022
Q1 | $1.89M | Sell |
|
|||||
|
2021
Q4 | $2.19M | Sell |
|
|||||
|
2021
Q3 | $1.85M | Sell |
|
|||||
|
2021
Q2 | $2.07M | Sell |
|
|||||
|
2021
Q1 | $2.46M | Buy |
|
|||||
|
2020
Q4 | $1.73M | Buy |
|
|||||
|
2020
Q3 | $754K | Buy |
|
|||||
|
2020
Q2 | $700K | Sell |
|
|||||
|
2020
Q1 | $1.21M | Buy |
|
|||||
|
2019
Q4 | $386K | Sell |
|
|||||
|
2019
Q3 | $307K | Hold |
|
|||||
|
2019
Q2 | $333K | Buy |
|
|||||
|
2019
Q1 | $269K | Hold |
|
|||||
|
2018
Q4 | $242K | Sell |
|
|||||
|
2018
Q3 | $359K | Hold |
|
|||||
|
2018
Q2 | $317K | Hold |
|
|||||
|
2018
Q1 | $304K | Hold |
|
|||||
|
2017
Q4 | $279K | Sell |
|
|||||
|
2017
Q3 | $287K | Buy |
|
|||||
|
2017
Q2 | $240K | Sell |
|
|||||
|
2017
Q1 | $233K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $216K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $224K | Hold |
|
|||||
|
2015
Q1 | $214K | Sell |
|
|||||
|
2014
Q4 | $295K | Hold |
|
|||||
|
2014
Q3 | $279K | Hold |
|
|||||
|
2014
Q2 | $235K | Buy |
|